{"id":"https://openalex.org/W2157995673","doi":"https://doi.org/10.1530/erc-10-0046","title":"Changes in breast cancer biomarkers in the IGF1R/PI3K pathway in recurrent breast cancer after tamoxifen treatment","display_name":"Changes in breast cancer biomarkers in the IGF1R/PI3K pathway in recurrent breast cancer after tamoxifen treatment","alternate_titles":[],"publication_year":2011,"publication_date":"2011-07-06","ids":{"openalex":"https://openalex.org/W2157995673","doi":"https://doi.org/10.1530/erc-10-0046","mag":"2157995673","pmid":"https://pubmed.ncbi.nlm.nih.gov/21734071"},"language":"en","primary_location":{"id":"doi:10.1530/erc-10-0046","doi":"https://doi.org/10.1530/erc-10-0046","is_oa":true,"landing_page_url":"https://doi.org/10.1530/erc-10-0046","pdf_url":"https://erc.bioscientifica.com/downloadpdf/journals/erc/18/5/565.pdf","source":{"id":"https://openalex.org/S193349529","display_name":"Endocrine Related Cancer","issn_l":"1351-0088","issn":["1351-0088","1479-6821"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319937","host_organization_name":"Bioscientifica","host_organization_lineage":["https://openalex.org/P4310319937"],"host_organization_lineage_names":["Bioscientifica"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrine-Related Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2157995673"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://erc.bioscientifica.com/downloadpdf/journals/erc/18/5/565.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090916718","display_name":"Suzanne C Drury","orcid":"https://orcid.org/0000-0001-7915-6072","observed_orcids":["https://orcid.org/0000-0001-7915-6072"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"S C Drury","raw_affiliation_strings":["Translational Research, The Breakthrough Breast Cancer Research Centre, London, UK. drurys@gosh.nhs.uk","Academic Biochemistry, Royal Marsden Hospital, London, UK","Translational Research, The Breakthrough Breast Cancer Research Centre, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Research, The Breakthrough Breast Cancer Research Centre, London, UK. drurys@gosh.nhs.uk","institution_ids":[]},{"raw_affiliation_string":"Academic Biochemistry, Royal Marsden Hospital, London, UK","institution_ids":["https://openalex.org/I4210121186"]},{"raw_affiliation_string":"Translational Research, The Breakthrough Breast Cancer Research Centre, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003319899","display_name":"Simone I. DETRE","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S Detre","raw_affiliation_strings":["Academic Biochemistry, Royal Marsden Hospital, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Biochemistry, Royal Marsden Hospital, London, UK","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025155327","display_name":"Alexandra F. Leary","orcid":"https://orcid.org/0000-0002-2043-2244","observed_orcids":["https://orcid.org/0000-0002-2043-2244"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A Leary","raw_affiliation_strings":["Royal Marsden Hospital, Sutton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Hospital, Sutton, UK","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108226891","display_name":"Janine Salter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J Salter","raw_affiliation_strings":["Academic Biochemistry, Royal Marsden Hospital, London, UK","Translational Research, The Breakthrough Breast Cancer Research Centre, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Biochemistry, Royal Marsden Hospital, London, UK","institution_ids":["https://openalex.org/I4210121186"]},{"raw_affiliation_string":"Translational Research, The Breakthrough Breast Cancer Research Centre, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077235697","display_name":"Jorge Sergio Reis-Filho","orcid":"https://orcid.org/0000-0003-2969-3173","observed_orcids":["https://orcid.org/0000-0003-2969-3173"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Reis-Filho","raw_affiliation_strings":["Molecular Pathology, The Breakthrough Breast Cancer Research Centre, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pathology, The Breakthrough Breast Cancer Research Centre, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025562072","display_name":"Violetta Barbashina","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V Barbashina","raw_affiliation_strings":["Molecular Pathology, The Breakthrough Breast Cancer Research Centre, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pathology, The Breakthrough Breast Cancer Research Centre, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065261887","display_name":"Caterina Marchi\u00f2","orcid":"https://orcid.org/0000-0003-2024-6131","observed_orcids":["https://orcid.org/0000-0003-2024-6131"]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"C Marchio","raw_affiliation_strings":["Department of Biomedical Sciences and Human Oncology, University of Turin, Via Santena 7, 10126 Turin, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Sciences and Human Oncology, University of Turin, Via Santena 7, 10126 Turin, Italy","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062099405","display_name":"Elena L\u00f3pez\u2010Knowles","orcid":"https://orcid.org/0000-0002-0893-3361","observed_orcids":["https://orcid.org/0000-0002-0893-3361"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Lopez-Knowles","raw_affiliation_strings":["Translational Research, The Breakthrough Breast Cancer Research Centre, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Research, The Breakthrough Breast Cancer Research Centre, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060583508","display_name":"Zara F. Ghazoui","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Z Ghazoui","raw_affiliation_strings":["Translational Research, The Breakthrough Breast Cancer Research Centre, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Research, The Breakthrough Breast Cancer Research Centre, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077077285","display_name":"Kai Habben","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Habben","raw_affiliation_strings":["Roche Diagnostics GmbH, Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Diagnostics GmbH, Penzberg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005166378","display_name":"Susanne Arbogast","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Arbogast","raw_affiliation_strings":["Roche Diagnostics GmbH, Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Diagnostics GmbH, Penzberg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031915637","display_name":"Stephen R.D. Johnston","orcid":"https://orcid.org/0000-0002-9072-2749","observed_orcids":["https://orcid.org/0000-0002-9072-2749","https://orcid.org/0000-0002-7641-6251"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S Johnston","raw_affiliation_strings":["Breast Unit, Royal Marsden Hospital, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast Unit, Royal Marsden Hospital, London, UK","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057689412","display_name":"Mitch Dowsett","orcid":"https://orcid.org/0000-0003-4122-744X","observed_orcids":["https://orcid.org/0000-0003-4122-744X"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M Dowsett","raw_affiliation_strings":["Academic Biochemistry, Royal Marsden Hospital, London, UK","Translational Research, The Breakthrough Breast Cancer Research Centre, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Biochemistry, Royal Marsden Hospital, London, UK","institution_ids":["https://openalex.org/I4210121186"]},{"raw_affiliation_string":"Translational Research, The Breakthrough Breast Cancer Research Centre, London, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5090916718"],"corresponding_institution_ids":["https://openalex.org/I4210121186"],"apc_list":null,"apc_paid":null,"fwci":2.9406,"has_fulltext":true,"cited_by_count":87,"citation_normalized_percentile":{"value":0.91063596,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"18","issue":"5","first_page":"565","last_page":"577"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.4375,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.4375,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.3434999883174896,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.09480000287294388,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tamoxifen-resistance","display_name":"tamoxifen resistance","score":0.9860000014305115},{"id":"https://openalex.org/keywords/breast-cancer-recurrence","display_name":"breast cancer recurrence","score":0.9089999794960022},{"id":"https://openalex.org/keywords/igf-1-receptor","display_name":"IGF-1 receptor","score":0.9020000100135803},{"id":"https://openalex.org/keywords/pi3k-signaling","display_name":"PI3K signaling","score":0.9919999837875366},{"id":"https://openalex.org/keywords/her2-overexpression","display_name":"HER2 overexpression","score":0.9869999885559082},{"id":"https://openalex.org/keywords/stathmin","display_name":"stathmin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pten-loss","display_name":"PTEN loss","score":0.9100000262260437},{"id":"https://openalex.org/keywords/pik3ca-mutation","display_name":"PIK3CA mutation","score":0.9810000061988831},{"id":"https://openalex.org/keywords/endocrine-resistance","display_name":"endocrine therapy resistance","score":0.6000000238418579},{"id":"https://openalex.org/keywords/breast-cancer-biomarkers","display_name":"breast cancer biomarkers","score":0.6759999990463257}],"concepts":[{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.781588077545166},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.779085099697113},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.684147834777832},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6672800183296204},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5456221699714661},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4316251277923584}],"mesh":[{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004815","descriptor_name":"Epidermal Growth Factor","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004965","descriptor_name":"Estrogen Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011960","descriptor_name":"Receptors, Estrogen","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011980","descriptor_name":"Receptors, Progesterone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013629","descriptor_name":"Tamoxifen","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D017526","descriptor_name":"Receptor, IGF Type 1","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D017526","descriptor_name":"Receptor, IGF Type 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D046888","descriptor_name":"Tissue Array Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050777","descriptor_name":"Stathmin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D051059","descriptor_name":"PTEN Phosphohydrolase","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D051059","descriptor_name":"PTEN Phosphohydrolase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1530/erc-10-0046","doi":"https://doi.org/10.1530/erc-10-0046","is_oa":true,"landing_page_url":"https://doi.org/10.1530/erc-10-0046","pdf_url":"https://erc.bioscientifica.com/downloadpdf/journals/erc/18/5/565.pdf","source":{"id":"https://openalex.org/S193349529","display_name":"Endocrine Related Cancer","issn_l":"1351-0088","issn":["1351-0088","1479-6821"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319937","host_organization_name":"Bioscientifica","host_organization_lineage":["https://openalex.org/P4310319937"],"host_organization_lineage_names":["Bioscientifica"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrine-Related Cancer","raw_type":"journal-article"},{"id":"pmid:21734071","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21734071","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrine-related cancer","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unito.it:2318/139808","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2318/139808","pdf_url":null,"source":{"id":"https://openalex.org/S4306400637","display_name":"Institutional Research Information System University of Turin (University of Turin)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I55143463","host_organization_name":"University of Turin","host_organization_lineage":["https://openalex.org/I55143463"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:zenodo.org:14301161","doi":null,"is_oa":true,"landing_page_url":"https://zenodo.org/records/14301161","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1530/erc-10-0046","doi":"https://doi.org/10.1530/erc-10-0046","is_oa":true,"landing_page_url":"https://doi.org/10.1530/erc-10-0046","pdf_url":"https://erc.bioscientifica.com/downloadpdf/journals/erc/18/5/565.pdf","source":{"id":"https://openalex.org/S193349529","display_name":"Endocrine Related Cancer","issn_l":"1351-0088","issn":["1351-0088","1479-6821"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319937","host_organization_name":"Bioscientifica","host_organization_lineage":["https://openalex.org/P4310319937"],"host_organization_lineage_names":["Bioscientifica"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrine-Related Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2157995673.pdf","grobid_xml":"https://content.openalex.org/works/W2157995673.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W8163034","https://openalex.org/W1495388995","https://openalex.org/W1497802607","https://openalex.org/W1510189975","https://openalex.org/W1562190372","https://openalex.org/W1565350682","https://openalex.org/W1634064292","https://openalex.org/W1673285127","https://openalex.org/W1853387493","https://openalex.org/W1967827870","https://openalex.org/W1968858823","https://openalex.org/W1971538947","https://openalex.org/W1983621028","https://openalex.org/W2027462603","https://openalex.org/W2027953312","https://openalex.org/W2029147710","https://openalex.org/W2029945937","https://openalex.org/W2047490464","https://openalex.org/W2079894826","https://openalex.org/W2087842578","https://openalex.org/W2101101419","https://openalex.org/W2105095453","https://openalex.org/W2106036365","https://openalex.org/W2113080446","https://openalex.org/W2116201594","https://openalex.org/W2118032571","https://openalex.org/W2127543264","https://openalex.org/W2128613144","https://openalex.org/W2137355132","https://openalex.org/W2143724133","https://openalex.org/W2144957807","https://openalex.org/W2146378328","https://openalex.org/W2146736665","https://openalex.org/W2152654745","https://openalex.org/W2153767954","https://openalex.org/W2156609440","https://openalex.org/W2163655381","https://openalex.org/W2164484108","https://openalex.org/W2167072194","https://openalex.org/W2172216132","https://openalex.org/W2608386464","https://openalex.org/W2901368272"],"related_works":["https://openalex.org/W2791003268","https://openalex.org/W2972169320","https://openalex.org/W2612257222","https://openalex.org/W2164484108","https://openalex.org/W2161062799","https://openalex.org/W348165835","https://openalex.org/W2243522470","https://openalex.org/W4324124894","https://openalex.org/W2099243061","https://openalex.org/W2163655381"],"abstract_inverted_index":{"Development":[0],"of":[1,12,28,33,80,88,149,155,192,202,208,231],"resistance":[2,62,89],"to":[3,68,90],"the":[4,39,83,99,232],"antioestrogen":[5],"tamoxifen":[6,43,222],"occurs":[7,30],"in":[8,31,60,73,86,107,153,162,180,210,221,225],"a":[9,78],"large":[10],"proportion":[11],"patients":[13],"with":[14,137,187],"oestrogen":[15],"receptor-positive":[16],"(ER+)":[17],"breast":[18,75],"cancer":[19,76],"and":[20,94,123,129,139,165,168,177,204,206,241],"is":[21,215],"an":[22],"important":[23],"clinical":[24,74],"challenge.":[25],"While":[26],"loss":[27,201,240],"ER":[29,128,203],"c.20%":[32],"tamoxifen-resistant":[34,96,212],"tumours,":[35],"this":[36,146],"cannot":[37],"be":[38,196],"sole":[40],"explanation":[41],"for":[42,77,105,218],"treatment":[44],"failure.":[45],"PI3K":[46,84,233],"pathway":[47,234],"activation,":[48],"including":[49],"by":[50],"insulin-like":[51],"growth":[52,114],"factor":[53,115],"receptor":[54,110,116],"1":[55],"(IGF1R),":[56],"has":[57],"been":[58],"implicated":[59],"some":[61,190,211],"models.":[63],"The":[64,198],"primary":[65,93],"aim":[66],"was":[67,159],"determine":[69],"whether":[70],"evidence":[71,217],"exists":[72],"role":[79],"IGF1R":[81,157,178,219],"and/or":[82],"pathway,":[85],"acquisition":[87],"tamoxifen.":[91],"Invasive":[92],"recurrent":[95,181],"tumours":[97],"from":[98],"same":[100],"patient":[101],"(n=77)":[102],"were":[103,132,245],"assessed":[104],"changes":[106],"ER,":[108,188],"progesterone":[109],"(PgR),":[111],"human":[112],"epidermal":[113],"2":[117],"(HER2),":[118],"IGF1R,":[119],"stathmin,":[120],"PTEN":[121,239],"expression":[122,158],"PIK3CA":[124,242],"mutations":[125,244],"where":[126],"possible.":[127],"PgR":[130,205],"levels":[131,170,227],"significantly":[133,160],"reduced":[134,161],"at":[135,145],"recurrence":[136],"22":[138],"45%,":[140],"respectively,":[141],"showing":[142],"negative":[143],"status":[144],"time.":[147],"Acquisition":[148],"HER2":[150,209],"overexpression":[151],"occurred":[152],"6%":[154],"cases.":[156],"both":[163],"ER+":[164],"ER-":[166],"recurrences":[167],"stathmin":[169,176,226],"increased.":[171],"A":[172],"positive":[173],"association":[174],"between":[175],"emerged":[179],"samples,":[182],"despite":[183],"their":[184,193],"opposing":[185],"relationships":[186],"suggesting":[189],"coalescence":[191],"activities":[194],"may":[195,235],"acquired.":[197],"data":[199],"confirm":[200],"gain":[207,220],"tumours.":[213],"There":[214],"no":[216],"resistance;":[223],"increases":[224],"suggest":[228],"that":[229],"activation":[230],"have":[236],"contributed,":[237],"but":[238],"hotspot":[243],"relatively":[246],"rare.":[247]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2157995673","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":14},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
